Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
IRTCthis companyiRhythm Technologies, Inc.	$88.88	-127.65×	37.18×	7.6×	-1,557.12×	-40.0%	70.6%	-4.9%	-6.0%	-29.2%	-4.2%	0.6%	4.79×	-124.89×	-2.8×	4.63×	0.0%	4	3.07	1	C-
ATRCAtriCure, Inc.	$57.78	-164.83×	3.84×	3.53×	111.39×	-104.6%	74.4%	-0.6%	-2.1%	-2.3%	-0.6%	2.6%	0.18×	-4.89×	-0.59×	3.96×	0.0%	8	11.96	3	B-
BEATHeartBeam, Inc.	$0.41	-3.87×	31.08×	0×	-3.65×	-74.8%	0.0%	0.0%	0.0%	-807.3%	-812.1%	-18.0%	0×	0.21×	0×	1.45×	0.0%	2	-11.41	1	C-
BSXBoston Scientific Corporation	$43.49	48.65×	5.82×	7.03×	29.7×	100.4%	69.0%	19.8%	14.4%	11.9%	8.8%	2.6%	0.51×	2.03×	11.38×	1.62×	0.0%	6	2.89	2	C+
HSCSHeartSciences Inc.	$2.91	-0.56×	0.02×	1,185.36×	-275.91×	-25040.1%	-2982.1%	-194787.4%	-211666.5%	-4.1%	-0.2%	-145.9%	17.46×	-275.29×	-11.17×	0.53×	0.0%	1	-41.58	2	C
KMTSKestra Medical Technologies, Ltd.	$29.36	-8.53×	4.66×	12.72×	-8.45×	-619.4%	51.4%	-141.6%	-138.4%	-50.7%	-43.7%	-9.6%	0.18×	0.39×	-17.85×	4.41×	0.0%	2	5.31	1	D+
Peer median	—	-3.87×	4.66×	7.03×	-3.65×	-104.6%	51.4%	-0.6%	-2.1%	-4.1%	-0.6%	-9.6%	0.18×	0.21×	-0.59×	1.62×	0.0%	2	2.89	2	—